Enclara Pharmacia Announces Appointment of New Vice President of Business Development
20 Sep 2022
Acquisition
Sept. 20, 2022 12:00 UTC
PHILADELPHIA--(BUSINESS WIRE)-- Enclara Pharmacia, the market leader in comprehensive pharmacy management services to the hospice community, has announced the appointment of Tim Sanderson as Vice President, Business Development. He will lead a national team of experts who take a consultative approach to helping hospices improve patient care, support their clinical staff, and maintain regulatory compliance, all while effectively managing costs.
Sanderson brings a strong background in hospice and pharmacy networks with nearly 20 years of experience in sales and consulting in the pharmacy benefit management (PBM) sector. Through his own firm, Pink Tie Consulting, he has used his finance and pharmacy services experience to help healthcare organizations and their clients build value-based relationships to improve profitability and patient care. He also taught finance, as well as mergers and acquisitions, at his alma matter Oral Roberts University.
“Tim’s deep understanding of hospice needs and pharmacy networks supports our mission to provide custom solutions designed for the unique needs of each hospice organization,” said Deanna Douglass, PharmD, SVP of Business Development, Enclara. “He will help articulate our value proposition, not only as a pharmacy provider but as a trusted partner for hospices seeking to improve care, manage costs and embrace new opportunities.”
Prior to founding Pink Tie Consulting, Sanderson worked with a publicly traded PBM and several hospice PBMs, developing expertise and relationships that make him an invaluable resource to the hospice community. His deep understanding of pharmacy networks, claims processing technology, integrations and transitions to new providers will provide immediate benefit to Enclara and hospices seeking innovative solutions to their pharmacy needs.
“I’m grateful to join Enclara because it’s a mission-driven company that puts the patient at the center of everything it does. Good care means immediate care and Enclara’s combined mail order and local access model supports that,” Sanderson said. “Enclara has also made it our mission to provide personal service to hospices of all shapes and sizes, from the smallest not-for-profits and sole proprietors to some of the nation’s largest hospice providers. That’s something I am super excited to be a part of.”
Sanderson holds a Bachelor of Science in finance and a Master of Business Administration from Oral Roberts University in Tulsa, OK with studies of finance and non-profit management during his graduate program.
About Enclara Pharmacia
Enclara Pharmacia is a national full-service PBM and mail order supplier of medications and clinical services developed specifically for the hospice and palliative care industry. Enclara serves over 600 hospice providers and 115,000 patients nationally, helping to reduce pharmacy costs through a clinically driven model that enables home delivery of pharmaceuticals as well as access to a network of over 65,000 local pharmacies, including an actively managed network subset of over 7,000 retail pharmacies, institutional pharmacies, and Enclara’s own automated fulfillment solutions.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.